Ecovyst Inc. — Form 8-K
Filed August 5, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 58/100
What the filing says
On June 30, 2026, Ecovyst completed acquisition of Calabrian sulfur dioxide and derivatives business from INEOS Enterprises, funded with $100M term loan increase. Q2 2026 continuing operations: sales $250.0M (+42% YoY), Adjusted EBITDA $53.1M (+27% YoY). Full-year 2026 Adjusted EBITDA guidance raised to $195M–$207M (from $180M–$195M), with Calabrian expected to contribute $10M–$12M H2 2026. Net debt leverage rose to 2.0x from 1.2x due to acquisition debt.
Why this rating
Acquisition materially expands product portfolio and addressable markets; $100M debt for ~$10–12M H2 EBITDA is ~11% relative to ~$932M market cap. Organic growth strong, but leverage increase and integration risk moderate upside near-term.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.